4.5 Article

Caregiver burden, health utilities, and institutional service use in Alzheimer's disease

Journal

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Volume 27, Issue 4, Pages 382-393

Publisher

WILEY
DOI: 10.1002/gps.2730

Keywords

Alzheimer's disease; service use; caregiver burden; Health Utilities Index; health status; correlates; institutions

Funding

  1. Eli Lilly
  2. Janssen Pharmaceutica
  3. Astra-Zeneca
  4. Wyeth Pharmaceuticals
  5. Bristol Myers Squibb
  6. Johnson and Johnson
  7. Pfizer
  8. NIMH [N01 MH9001]

Ask authors/readers for more resources

Objective: This study examined the moderating effect of caregiver burden on the relationship between the health status of Alzheimer's disease (AD) patients and their use of institutional services (i.e., hospitalization, nursing home, and residential care). Methods: Data were obtained at baseline and at 3, 6, and 9 months following study entry on 421 community-dwelling patients with AD in the Clinical Antipsychotic Trials of Intervention Effectiveness for AD. The outcome variable includes use of any institutional services. Logistic regression was employed to estimate the interaction between Health Utility Index Mark III score (a general health status measure) and four concurrent caregiver burden measures at outcome. Marginal effects were calculated and plotted using random effects models for observations at multiple time points per individual. Average effects were calculated across all observations using models without random effects. Results: Random effects results suggest that caregiver burden weakens the inverse relationship between health utilities and institutional service use, leading to greater likelihood of institutional use than would be expected at a given level of health. This is indicated by positive and significant signs on the Health Utility Index Mark III(star)caregiver burden interaction when burden is measured using the Caregiver Distress Scale, Beck Depression Inventory, and Caregiver Assessment Survey (all p < 0.05). It is reinforced by positive and significant average effects deriving from Caregiver Distress and Beck Depression Inventory models without random effects (both p < 0.10). Results derived from the Burden Interview Scale, although positive, were non-significant and weak by comparison. Conclusion: Caregiver support interventions should be offered to individuals caring for less-advanced AD patients. Otherwise, healthy patients may be at increased risk for institutionalization when caregivers experience high levels of burden. Copyright (C) 2011 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available